Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

PHIO

PHIO News

Newswire

16:16

Phio Pharmaceuticals completes enrollment in Phase 1b clinical trial of INTASYL siRNA PH-762.

13:00

Phio Pharmaceuticals CEO Robert Bitterman Buys 5,000 Shares at $1.14 on 2023-11-21.

05:49

Phio Pharmaceuticals shares fall 10.08% premarket after selling stockholders file 11.8M share offering.

12:54

Phio Pharmaceuticals CEO Robert J Bitterman Buys 5,000 Shares at $1.27/Share

10:00

Phio Pharmaceuticals (PHIO) down more than 70% since Nov 3

View More

About PHIO

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More